Shoolin Pharma LLP | Clinical Trials Search

13,814 results for “Shoolin Pharma LLP”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

First posted Jun 12, 2006

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

24 participants · First posted Jun 29, 2016

Exjade-Early-Trial

2 participants · First posted Jan 28, 2010

Bioequivalence Study of Fingolimod From Sphingomod 0.5 mg Hard Gelatin Capsules (Hikma Pharma, Egypt) Versus Gilenya 0.5 mg Hard Capsules (Novartis Pharma AG, Basle, Switzerland).

34 participants · First posted Dec 8, 2020

Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus Vesicare 5 mg FCT & Betmiga 50 mg Prolonged-Release Tablets (Astellas Pharma Europe B.V, the Netherlands / Astellas Pharma Europe B.V, the Netherlands)

30 participants · First posted Mar 14, 2023

Enrolling By Invitation

Compined Lumber Longissimus Plane Block and Multifidus Longissimus Plane Block Versus Infiltration Field Block in Lumber Spine Surgery

50 participants · First posted Jul 2, 2026

Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.

32 participants · First posted Oct 3, 2023

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

242 participants · First posted Feb 7, 2020

IRCT20200105046010N103

In-vivo Bioequivalence Study of Ranolazine 500 mg extended-release tablets (Arang Pharma, Iran)

24 participants

Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

390 participants · First posted Nov 24, 2020

Page 1 of 559